Proof of concept: prognostic value of the plasmatic concentration of circulating cell free DNA in desmoid tumors using ddPCR - Centre Oscar Lambret Accéder directement au contenu
Article Dans Une Revue Oncotarget Année : 2018

Proof of concept: prognostic value of the plasmatic concentration of circulating cell free DNA in desmoid tumors using ddPCR

Résumé

Since desmoid tumors (DT) exhibit an unpredictable clinical course, with stabilization and/or spontaneous regression, an initial “wait-and-see” policy is the new standard of care–thus, the actual challenge is to identify early factors of progression. We present a method of detection of CTNNB1 mutations using a targeted digital droplet PCR (ddPCR) on cell-free DNA (cfDNA) extracted from blood samples of 31 DT patients. Furthermore, we analyzed the correlation between DT evolution and plasmatic concentration of total and mutated cfDNA at the time of diagnosis. Circulating copies of CTNNB1 mutants (ctDNA) were detected in the plasma of 6 patients (33%) but their concentration was not correlated with evolution of the tumor. Concentration of total cfDNA was higher in the plasma of patients with progressive desmoids (p = 0,0009). Using a threshold <900 copies/mL of plasma to detect indolent desmoid and a threshold >1375, it was possible to predict desmoid evolution for 65% of patients by measuring the quantity of circulating DNA in their plasma as early as the time of diagnosis. Albeit showing that the detection of CTNNB1 mutants is possible in the plasma of patients harboring a desmoid tumor, the results of this preliminary study raise the hypothesis that most of the circulating DNA detected in their plasma is derived from non-neoplastic cells, most likely normal neighboring tissues being actively invaded. Our results open the perspective of using cfDNA as a biomarker to predict prognosis at the time of diagnosis and assess tumor dynamics to optimize the treatment strategy.
Fichier principal
Vignette du fichier
24817-346758-4-PB.pdf (2.55 Mo) Télécharger le fichier
24817-346764-2-SP.pdf (1.04 Mo) Télécharger le fichier
24817-346765-1-SP.xlsx (17.45 Ko) Télécharger le fichier
24817-346766-1-SP.pdf (242.21 Ko) Télécharger le fichier
24817-346767-1-SP.pdf (405.14 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-01794155 , version 1 (17-05-2018)

Identifiants

Citer

Nicolas Macagno, Frédéric Fina, Nicolas Penel, Corinne Bouvier, Isabelle Nanni, et al.. Proof of concept: prognostic value of the plasmatic concentration of circulating cell free DNA in desmoid tumors using ddPCR. Oncotarget, 2018, 9 (26), pp.18296-18308. ⟨10.18632/oncotarget.24817⟩. ⟨hal-01794155⟩
212 Consultations
154 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More